| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.003 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |